Learn how CD34+ stem cells may help heart attack patients recover. A look at cutting-edge cell therapies and what's coming ...

A cell therapy for regenerating broken spinal cord using lab-grown neurons enters human trials for the first time.

Japan’s foray into regenerative medicine takes on added importance for a nation wrestling with age, stagnation, and its place ...

A lab-designed molecule developed and extensively studied by scientists with Virginia Tech's Fralin Biomedical Research ...

A lab-designed molecule developed and extensively studied by scientists with Virginia Tech's Fralin Biomedical Research ...

The Danish drugmaker has acquired exclusive rights outside Japan to Heartseed's HS-001 therapy based on heart muscle cells (cardiomyocytes) derived from human stem cells, and is due to start the ...

The large molecule injectable drugs market is anticipated to expand at a CAGR of ~9% during the forecast period. Key drivers ...

A compound found in nearly every energy drink may also be feeding aggressive blood cancers. Researchers discovered that ...

It is the first trial in the US to study pluripotent stem cell-derived ... degenerative heart disease, and autoimmune disorders. Bayer is also developing a gene therapy for Parkinson's originated ...

BACKGROUND: Dilated cardiomyopathy (DCM) is substantially influenced by genetic factors. Sarcomere function is intricately associated with other organelles, particularly the reciprocal regulation ...